Dr. Chenyang Xu is currently the President and Co-Chairman of PVmed Technologies, Co-Founding Partner of Silicon Valley Future Academy, Managing Partner of Brightway Future Capital, and an Advisory Board Member for the Johns Hopkins University BME department and formerly Advisory Board Member for the UC Berkeley EECS Department.

He was formerly the Chief Business Officer of RSP Systems and the GM and CTO of Siemens Technology to Business (TTB) at Berkeley where he led the Siemens’s North America’s technology startup partnership and early-stage investment practice out of the Silicon Valley. As former head of Siemens Interventional Imaging Program, he led an R&D team that developed over 10 new computer vision-based medical imaging products (e.g. CartoMerge) and has achieved billion dollar scale new revenue stream.

Follow us on Twitter! @TheMaMLPodcast

Guest: Chenyang Xu

Host: David Wu / Twitter: @davidjhwu

Producer: Aaron Schumacher / Twitter: @a_schu95

Artwork & Video: Saurin Kantesaria

Music: Caligula - Windows96. Used with Artist Permission.

01:00 - tell us about your path

11:00 - the internet + grad school in the 90s

22:00 - “career thinking” advice

30:30 - Siemens VC - looking at 10,000 startups

37:00 - PVMed - AI cancer treatment company in China

43:30 - AI startup ecosystem in China vs. US vs. Europe

56:30 - Potential downsides of implementing AI too quickly?

1:02:10 - Future of AI in medicine in 10-20 yrs?

1:13:00 - “Minority Report”-like AI to predict falls?

1:16:30 - Closing Questions